We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUY
4076
CALL
DELISTED
Yamana Gold, Inc.
AUY
-42,500
Closed -$5K
CAJ
4077
DELISTED
Canon, Inc.
CAJ
-15,878
Closed -$346K
WEBR
4078
DELISTED
Weber Inc.
WEBR
-36,698
Closed -$241K
VLDR
4079
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
-15,896
Closed -$15K
FNI
4080
DELISTED
First Trust Chindia ETF
FNI
-7,380
Closed -$258K
CORZ
4081
DELISTED
Core Scientific, Inc. Common Stock
CORZ
-26,953
Closed -$35K
MNRL
4082
CALL
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
-61,500
Closed -$49K
MNRL
4083
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
-286,030
Closed -$7.06M
LFG
4084
DELISTED
Archaea Energy Inc.
LFG
-17,611
Closed -$317K
ABMD
4085
DELISTED
Abiomed Inc
ABMD
-884
Closed -$217K
BSMM
4086
DELISTED
Invesco BulletShares 2022 Municipal Bond ETF
BSMM
-25,272
Closed -$639K
BSJM
4087
DELISTED
Invesco BulletShares 2022 High Yield Corporate Bond ETF
BSJM
-28,066
Closed -$617K
IBTB
4088
DELISTED
iShares iBonds Dec 2022 Term Treasury ETF
IBTB
-386,551
Closed -$9.81M
LOTZ
4089
DELISTED
CarLotz, Inc. Class A Common Stock
LOTZ
-268,950
Closed -$81K
SWCH
4090
DELISTED
Switch, Inc. Class A Common Stock
SWCH
-306,181
Closed -$10.3M
IBMK
4091
DELISTED
iShares iBonds Dec 2022 Term Muni Bond ETF
IBMK
-162,006
Closed -$4.2M
PBFX
4092
DELISTED
PBF LOGISTICS LP
PBFX
-43,889
Closed -$829K
JEMD
4093
DELISTED
Nuveen Emerging Markets Debt 2022 Target Term Fund, Common Shares of Beneficial Interest, $0.01 par value per share
JEMD
-11,724
Closed -$75K
CLR
4094
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-61,737
Closed -$4.13M
TEN
4095
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
-36,500
Closed -$635K
STON
4096
DELISTED
StoneMor Inc.
STON
-11,880
Closed -$41K
PHAS
4097
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
-15,500
Closed -$3K
TWTR
4098
DELISTED
Twitter, Inc.
TWTR
-439,124
Closed -$19.3M
EFL
4099
DELISTED
Eaton Vance Floating-Rate 2022 Target Term Trust Common Shares of Beneficial Interest
EFL
-77,280
Closed -$665K
CCXI
4100
DELISTED
ChemoCentryx, Inc.
CCXI
-41,068
Closed -$2.12M

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.